Are You a Candidate for TMS?

At Hendricks Therapy, your care is our highest priority. We are dedicated to providing you with all the necessary tools and information to make your TMS therapy as comfortable and effective as possible.

Our friendly staff is available to address any of your questions or concerns. They will help you understand how TMS is used in the treatment of depression, what to expect from TMS therapy, and support you in your mental health journey.

We ask that you complete the questionnaire to determine eligibility for TMS Therapy.

PATIENT QUESTIONNAIRE

Who Can Benefit from TMS

TMS is recommended for patients who:

  • Have tried various rounds of different medications and psychotherapy with no relief from their symptoms

  • Do not have any metal implant within the head

  • Want to avoid the side effects of medication

  • Are planning to become pregnant

  • Do not have a seizure disorder or a history of seizures

What to Expect at Your Consultation

A thorough assessment of your symptoms, treatment history, and other health factors is needed to determine if you qualify for Transcranial Magnetic Stimulation (TMS) Therapy. Once TMS therapy is prescribed, an initial appointment will be scheduled for a 1-2 hour session.

TMS is non-invasive and non-systemic. Patients are awake during the treatment and can resume normal activities the rest of the day. The patient sits in a comfortable chair during the procedure as magnetic pulses are administered, resulting in the following:

  1. The release of neurotransmitters

  2. Increased blood flow to the brain

  3. Other positive clinical effects

    How Effective Is TMS Treatment?

    30 clinical trials with 2,000 patients showed TMS to be effective for treating depression

    In real world naturalistic studies, between 58% and 75% of patients treated with TMS experienced significant improvement1

    Recorded data for over 1000 participants undergoing a course of Deep TMS treatment for MDD, one out of two achieving remission of the patients went into remission, which is the full relief of their symptoms2 

    People treated with TMS were 2-4 times more likely to achieve remission from depression symptoms, compared to people treated with antidepressants alone3

    62.5% of people treated with TMS who experienced relief continued to show improvement after 1 year4

    Conditions that Transcranial Magnetic Stimulation (TMS) Can Treat

    In the United States, TMS is only FDA-approved for treatment-resistant major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). However, many clinical trials have shown that TMS can safely and effectively treat other conditions, such as:

    • Addiction/substance abuse disorders

    • Alcohol addiction

    • Anxiety

    • ADHD

    • Parkinson’s disease

    • PTSD (post-traumatic stress disorder)

    • Tobacco/nicotine addiction

    Learn more about other conditions TMS can treat.

    Resources:
    1. Carpenter LL et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. Link. 2012;29(7):587-96.
    2. O’Reardon JP et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biol Psychiatry. Link. 2007; 62(11):1208-16.
    3. George MS et al. Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder. Arch Gen Psychiatry. Link. 2010;67(5):507-16.
    4. Dunner DL et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. Link. 2014;75(12):1394-401.
    5. L.Carmi et al. Deep Transcranial Magnetic Stimulation (TMS) in Obsessive Compulsive Disorder (Ocd) Patients. European Psychiatry. Published March 2015. Link. Accessed July 09, 2020.
    6. Paulesu E, Sambugaro E, Torti T, Danelli L, Ferri F, Scialfa G, Sberna M, Ruggiero GM, Bottini G, Sassaroli S. Neural correlates of worry in generalized anxiety disorder and in normal controls: a functional MRI study. Psychological Medicine. 2010;40(1):117-124. Link. Accessed July 09, 2020.
    7. Namgung E, Kim M, and Yoon S. Repetitive transcranial magnetic stimulation in trauma-related conditions. Neuropsychiatric Disease and Treatment. 2019;15:701–712. Link. Accessed July 09, 2020.
    8. Khedr EM, Al-Fawal B, Abdel Wraith A, Saber M, Hasan AM, Bassiony A, Nasr Eldein A, Ahmeda, and Rothwell JC. The Effect of 20 Hz versus 1 Hz Repetitive Transcranial Magnetic Stimulation on Motor Dysfunction in Parkinson’s Disease: Which Is More Beneficial? Journal of Parkinson’s Disease. 2019;9(2):379-387. Link. Accessed July 09, 2020.
    9. Cao P, Xing J, Cao Y, Cheng Q, Sun X, Kang Q, Dai L, Zhou X, and Song Z. Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder. Neuropsychiatric Disease and Treatment. 2018;14:3231-3240. Link. Accessed July 09, 2020.
    10. FDA NEWS RELEASE. FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder. Press Announcements. Published August 17, 2018. Link. Accessed August 28, 2020.